Pancreatic Cancer Health Disparity: Pharmacologic Anthropology

SIMPLE SUMMARY: Pancreatic cancer (PCa) is a highly aggressive and deadly form of cancer with a low five-year survival rate. This paper explores the role of pharmacologic anthropology in understanding and addressing health disparities related to PCa. Pharmacologic anthropology examines how cultural, social, economic, and behavioral factors affect the use and effectiveness of pharmaceutical treatments. In the context of PCa, it helps us understand why different population groups experience disparities in PCa outcomes. By adopting this interdisciplinary approach, researchers, healthcare providers, and policymakers can better understand the complex dynamics of PCa health disparities. This understanding can lead to culturally sensitive interventions, improved communication between patients and providers, increased community engagement, and policies that enhance access to quality care for all PCa patients. ABSTRACT: Pancreatic cancer (PCa) remains a formidable global health challenge, with high mortality rates and limited treatment options. While advancements in pharmacology have led to improved outcomes for various cancers, PCa continues to exhibit significant health disparities, disproportionately affecting certain populations. This paper explores the intersection of pharmacology and anthropology in understanding the health disparities associated with PCa. By considering the socio-cultural, economic, and behavioral factors that influence the development, diagnosis, treatment, and outcomes of PCa, pharmacologic anthropology provides a comprehensive framework to address these disparities and improve patient care.